Ledger.Open graph →

SEC Form D · filed May 25, 2023

Salarius Pharmaceuticals, Inc

Offering

$6.0M

Sold

$6.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Houston, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Tess K. Burleson · Houston, TXDirector Paul C. Lammers · Houston, TXDirector Jennifer Staciokas · Murrells Inlet, SCExec · Director William K. Mcvicar · Houston, TXDirector Bruce J. Mccreedy · Houston, TXDirector Jonathan C. Lieber · Houston, TXDirector Mark J. Rosenblum · Houston, TXExec Arnold C. Hanish · Houston, TXDirector Qasar Younis · San Francisco, CADirector Andrew L. Nehlig · Asheville, NCDirector Hemant Taneja · San Francisco, CADirector Alexander Schneider · Cleveland, OHDirector Luke Visnic · Cleveland, OHDirector Mark Anderson · JACKSONVILLE, FLDirector Teresa Carlson · San Francisco, CAExec Ivy Zhang · San Diego, CADirector Saundra Pelletier · San Diego, CADirector Ndukwe Kalu · HOUSTON, TXExec Chetachi Ozougwu · HOUSTON, TXDirector Adrayll Askew · HOUSTON, TXDirector Brian Buenneke · San Francisco, CADirector Tony O'Brien · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗